Work

Pomalidomide, bortezomib and dexamethasone in multiple myeloma refractory to lenalidomide and anti-CD38 monoclonal antibodies: outcomes from a real-world experience

Year: 2026
Type: article
Abstract: Not available.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,157
OpenAlex ID: W7140716533
FWCI:
Cites:
Cited by:
Related to: